FNY Managed Accounts’s Medtronic MDT Stock Holding History

FNY Managed Accounts’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-4,000	Closed	-$323K	–	736
2017 Q4	$323K	Buy	+4,000	New	+$320K	0.3%	33

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

FNY Managed Accounts's MDT Position: Q1 2018 in Review

FNY Managed Accounts sold out of Medtronic (MDT) in Q1 2018, closing a stake of 4,000 shares — an estimated $323K sold.

FNY Managed Accounts first reported a position in MDT in Q4 2017 and held it in 1 quarter. The position peaked at $323K in Q4 2017. 1,382 funds tracked by Wall St. Rank hold MDT as of Q1 2018.

FNY Managed Accounts reported no remaining Medtronic position as of Q1 2018 after selling out during the quarter.
FNY Managed Accounts sold 4,000 Medtronic shares in Q1 2018, an estimated $323K.
FNY Managed Accounts first reported a position in Medtronic in Q4 2017 and held it in 1 quarter.
FNY Managed Accounts's Medtronic position peaked at $323K in Q4 2017.
1,382 funds tracked by Wall St. Rank held Medtronic as of Q1 2018.

Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.